About this trial
This is a single-center, comparative, observational study. Datasets will be collected from patients with pathologically confirmed colon cancer who undergo abdomen-pelvis enhanced spectral CT scan.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients pathologically confirmed with colon cancer via endoscopic biopsy.
Patients who underwent preoperative abdominopelvic enhanced spectral CT.
Study participant with age ≥ 18 years old.
Study participants that have signed Informed Consent Form (ICF).
Disqualifiers
The clinical data or pathological information is considered incomplete after evaluation by the investigator.
The investigator determined that poor image quality (e.g. obvious artifacts, missing critical scan layers) would not satisfy post-processing analysis.
Data of patients deemed inappropriate for inclusion after evaluation by the investigator.
Trial population
Patients with colon cancer aged 18.
Trial design
Case-control
Cross-sectional
Treatments tested in this trial
This is an observational study
DeviceThis is an observational study
Treatment groups
Trial outcomes
Primary outcomes
subjective overall Image quality using 5-point Likert scale(1-5)
Radiologist will evaluate the overall image quality using 5 Likert scale ranging from 1(poor) to 5 (Excellent)
Objective image quality
The objective image quality is evaluated by measuring the CT value shown in the image.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Philips Clinical & Medical Affairs Global
Lead sponsor
Sun Yat-Sen University Cancer Center
Collaborator
This trial is not recruiting at the moment. You can still explore other options: